We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Moderna
MRNA
$22B
| $1.1M | 0.05% |
+75,249
| New | +$1.62M |
|
352
AGCO
AGCO
$8.98B
| $1.09M | 0.05% |
+14,102
| New | +$1.01M |
|
353
Ingersoll Rand
IR
$33.8B
| $1.09M | 0.05% |
31,606
+91
| +0.3% | +$2.94K |
|
354
Mercado Libre
MELI
$94.4B
| $1.09M | 0.05% |
1,783
-1,542
| -46% | -$858K |
|
|
TWTR
355
DELISTED
Twitter, Inc.
TWTR
| $1.07M | 0.05% |
+30,620
| New | +$1.12M |
|
356
Pembina Pipeline
PBA
$29.1B
| $1.06M | 0.05% |
28,628
-18,908
| -40% | -$689K |
|
357
Cirrus Logic
CRUS
$6.89B
| $1.06M | 0.05% |
+24,286
| New | +$1.06M |
|
358
Alnylam Pharmaceuticals
ALNY
$38.3B
| $1.06M | 0.05% |
+14,571
| New | +$1.12M |
|
359
Integra LifeSciences
IART
$1.53B
| $1.05M | 0.05% |
18,805
-6,554
| -26% | -$338K |
|
360
BWX Technologies
BWXT
$15.6B
| $1.05M | 0.05% |
20,140
+11,665
| +138% | +$582K |
|
361
Synaptics
SYNA
$4.38B
| $1.04M | 0.05% |
+35,664
| New | +$1.16M |
|
362
Martin Marietta Materials
MLM
$34.9B
| $1.03M | 0.05% |
+4,483
| New | +$971K |
|
363
Universal Display
OLED
$3.87B
| $1.03M | 0.05% |
+5,489
| New | +$913K |
|
364
Hasbro
HAS
$13.6B
| $1.03M | 0.05% |
+9,734
| New | +$959K |
|
365
Amcor
AMCR
$21.6B
| $1.03M | 0.05% |
+17,868
| New | +$992K |
|
|
CVET
366
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.01M | 0.05% |
41,466
+17,447
| +73% | +$503K |
|
367
MarketAxess Holdings
MKTX
$4.31B
| $1.01M | 0.05% |
3,132
-2,608
| -45% | -$754K |
|
|
TCF
368
DELISTED
TCF Financial Corporation Common Stock
TCF
| $995K | 0.04% |
24,202
-6,496
| -21% | -$270K |
|
|
AYX
369
DELISTED
Alteryx Inc
AYX
| $991K | 0.04% |
+9,085
| New | +$827K |
|
|
RPAI
370
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $986K | 0.04% |
+83,881
| New | +$1.03M |
|
371
NETSCOUT
NTCT
$2.9B
| $985K | 0.04% |
+38,805
| New | +$1.04M |
|
372
MillerKnoll
MLKN
$1.6B
| $982K | 0.04% |
21,963
-7,704
| -26% | -$291K |
|
373
Black Hills Corp
BKH
$5.73B
| $967K | 0.04% |
+12,373
| New | +$932K |
|
374
Lamar Advertising Co
LAMR
$16.5B
| $961K | 0.04% |
11,903
-29,422
| -71% | -$2.38M |
|
|
SJR
375
DELISTED
Shaw Communications Inc.
SJR
| $960K | 0.04% |
47,089
-271
| -0.6% | -$5.52K |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.